Company / Accounts Receivable
CorVel Corporation Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$104.1M
FY2025
5-year range
$64.7M / $104.1M
FY2021-FY2025
Trend
+7.2%
vs FY2024
Sector context
#96 of 143
Health Care
What the data says
At $104M, CorVel Corporation's accounts receivable ranks #96 of 143 in the Health Care sector. Accounts Receivable has fluctuated over the past 10 years, ranging from $60M in FY2016 to $104M in FY2025.
Based on SEC 10-K filings.
$104M in FY2025 with a 5-year CAGR of +9.6%.
Improved from $81M to $104M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +8.0%
- 5-Year CAGR
- +9.6%
- 10-Year CAGR
- -
Sector benchmark
#96 of 143 in Health CareTop 67% of 143This company $104.1M Sector average $1.3B
▼
-92.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.6%, indicating consistent growth.
- In FY2025, accounts receivable increased 7.2% year-over-year.
- Ranks #96 out of 143 companies in the Health Care sector.
- Lowest accounts receivable in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $104.1M | +7.2% |
| FY2024 | $97.1M | +19.8% |
| FY2023 | $81.0M | -1.9% |
| FY2022 | $82.6M | +27.6% |
| FY2021 | $64.7M | -1.6% |
| FY2020 | $65.8M | -7.8% |
| FY2019 | $71.3M | +9.8% |
| FY2018 | $64.9M | +3.3% |
| FY2017 | $62.8M | +5.2% |
| FY2016 | $59.7M | +3.8% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026